Real‐World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido‐ TZP Study

Key Points

• The aim is to evaluate the effectiveness and safety of tirzepatide in managing metabolic abnormalities associated with type 2 diabetes.
• Conducted a multicenter retrospective observational analysis.
• Included subjects with type 2 diabetes receiving tirzepatide.
• Assessed clinical outcomes related to metabolic abnormalities.
• Tirzepatide showed robust efficacy in improving metabolic parameters.
• Safety profile was favorable regardless of prior incretin therapy.

Abstract